To investigate the feasibility and usability of the RM Partners Cancer Hub model in delivering elective colorectal and anal cancer surgery services during the COVID-19 pandemic, particularly in light of the pandemic's impact on healthcare delivery.
Key Findings:
The RM Partners Cancer Hub effectively centralized resources for colorectal cancer care during the pandemic, with a reported reduction in surgery-related complications.
Designated 'COVID-19 free' surgical sites allowed for safe elective surgeries, with infection rates monitored.
Strategic prioritization of cases minimized complications from delays, with a noted improvement in patient outcomes.
Interpretation:
The establishment of the RM Partners Cancer Hub demonstrated that a regional collaborative model can maintain essential cancer services during public health crises.
Limitations:
The study is retrospective and may not capture all variables affecting outcomes, such as patient demographics and comorbidities.
Findings may not be generalizable beyond the specific context of the UK healthcare system, particularly in regions with different healthcare structures.
Conclusion:
The RM Partners Cancer Hub model proved feasible and effective in delivering colorectal cancer services during the COVID-19 pandemic, ensuring patient safety and continuity of care.
The rising incidence and mortality of early-onset colorectal cancer (EOCRC), defined as disease occurring in patients younger than 50, has emerged as a clinically significant trend with implications for screening, diagnosis, and survivorship.
